openPR Logo
Press release

Elevated Cardiovascular Disease Rates Propel Left Ventricular Assist Device Market: A Key Catalyst Accelerating Left Ventricular Assist Devices Market Growth in 2025

07-17-2025 07:45 AM CET | Health & Medicine

Press release from: The Business Research Company

Left Ventricular Assist Devices

Left Ventricular Assist Devices

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Left Ventricular Assist Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for left ventricular assist devices has seen robust growth in recent times. The market is predicted to expand from $1.6 billion in 2024 to $1.74 billion in 2025, marking a compound annual growth rate (CAGR) of 8.8%. Factors contributing to the growth during the historic period include post-market monitoring and data collection, downsizing of the device and reducing noise, initiatives aimed at raising awareness and education, enhanced physician experience, and the devices' use in bridge therapy.

Left Ventricular Assist Devices Market Size Forecast: What's the Projected Valuation by 2029?
In the upcoming years, the market size of left ventricular assist devices is anticipated to experience significant expansion. By 2029, it is projected to reach a market value of $2.52 billion, with a compound annual growth rate (CAGR) of 9.6%. This development in the forecasted timeline could be a result of broadened indications, increased incidents of heart failure, improved patient outcomes, market acceptance, and adjustments in regulations, all of which are geared towards destination therapy. Within this same period, the market is expected to see major trends such as enhanced implantation methods, the creation of dual-pump systems, an increased application in destination therapy, an emphasis on reducing risks of infection, combination with heart failure management plans, and more efficient management of anticoagulation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/left-ventricular-assist-devices-global-market-report

What Are the Drivers Transforming the Left Ventricular Assist Devices Market?
The growth of the left ventricular assist device market is anticipated to be driven by the increasing incidence of cardiovascular diseases. Cardiovascular diseases include a variety of heart and blood vessel disorders such as coronary heart disease and congenital heart disease. For individuals suffering from severe heart failure, a left ventricular assist device is used to assist the heart's left ventricle, which is responsible for pumping blood to the body tissues. For example, figures released by the UK's Office for Health Improvement and Disparities in March 2024 showed that as of 2023, slightly over 1,862,500 people (3%) had a GP diagnosis of coronary heart disease in England. Additionally, data released by the New York government in December 2022 disclosed that heart disease leads to approximately 697,000 deaths annually in the United States which accounts for 1 in every 5 fatalities. Of these fatalities, around 805,000 Americans experience a heart attack each year, with 605,000 of them suffering their first heart attack and 200,000 being the result of previous heart attacks. As a result, the escalating incidence of cardiovascular diseases is fuelling the expansion of the left ventricular assist device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12042&type=smp

What Long-Term Trends Will Define the Future of the Left Ventricular Assist Devices Market?
Leading corporations in the left ventricular assist devices market are focusing on advancing technologies like power management units (PMUs) to improve the effectiveness, durability, and dependability of their devices. A power management unit (PMU) is an integrated circuit designed to control and maintain power distribution and supply in various electronic device components. For instance, in June 2022, the semiconductor manufacturer based in Japan, Renesas Electronics, introduced the SmartBond DA1470x. This family of SmartBond DA1470x represents considerable progress in BLE technology and provides developers a flexible platform to develop creative IoT products while optimizing expenses and boosting performance. The high degree of integration enables simplified design, enhanced reliability, and a faster path to market for numerous applications.

Which Segments in the Left Ventricular Assist Devices Market Offer the Most Profit Potential?
The left ventricular assist devices market covered in this report is segmented -

1) By Type: Transcutaneous Left Ventricular Assist Devices, Implantable Left Ventricular Assist Devices
2) By Type Of Flow: Pulsatile, Non-Pulsatile
3) By Application: Bridge-To-Recovery (BTR) Therapy, Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy
4) By End-User: Cardiology Centers, Hospitals

Subsegments:
1) By Transcutaneous Left Ventricular Assist Devices: Temporary Transcutaneous Devices, Permanent Transcutaneous Devices
2) By Implantable Left Ventricular Assist Devices: Continuous Flow Devices, Pulsatile Flow Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12042&type=smp

Which Firms Dominate the Left Ventricular Assist Devices Market by Market Share and Revenue in 2025?
Major companies operating in the left ventricular assist devices market include Abbott Laboratories, Medtronic plc., Terumo Corporation, St. Jude Medical, MAQUET GmbH & Co., LivaNova Plc, Thoratec Corporation, Abiomed Inc, Transonic Systems, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc., Leviticus Cardio Ltd., AdjuCor GmbH, Calon Cardio-Technology Ltd, Evaheart Inc., Sunshine Heart Inc., CH Biomedical Inc., Sun Medical Technology Research Corp

Which Regions Offer the Highest Growth Potential in the Left Ventricular Assist Devices Market?
North America was the largest region in the left ventricular assist devices market in 2024. The regions covered in the left ventricular assist devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12042

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Elevated Cardiovascular Disease Rates Propel Left Ventricular Assist Device Market: A Key Catalyst Accelerating Left Ventricular Assist Devices Market Growth in 2025 here

News-ID: 4107422 • Views:

More Releases from The Business Research Company

Global Subcutaneous Immunoglobulin (SCIG) Market Projected to Grow at 12.7% CAGR, Reaching $23.23 Billion by 2029
Global Subcutaneous Immunoglobulin (SCIG) Market Projected to Grow at 12.7% CAGR …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Subcutaneous Immunoglobulin (SCIG) Industry Market Size Be by 2025? The market for subcutaneous immunoglobulin (SCIG) has seen a swift expansion in the recent past. The market size is projected to escalate from $12.72 billion in 2024 to $14.39 billion in 2025, reflecting a compound annual growth
2025-2034 Ranibizumab Market Roadmap: Insights for Competitive Advantage
2025-2034 Ranibizumab Market Roadmap: Insights for Competitive Advantage
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Ranibizumab Market Size By 2025? The market for ranibizumab has experienced steady expansion in the past few years, with projections stating it will increase from $2.66 billion in 2024 to $2.76 billion in 2025, indicating a compound annual growth rate (CAGR) of 3.6%. The growth
Emerging Peptide And Oligonucleotide CDMO Market Trends: Strategic Partnerships In Peptide And Oligonucleotide CDMO Market Boost Technological Capabilities And Market Reach Shaping the Future of the Industry
Emerging Peptide And Oligonucleotide CDMO Market Trends: Strategic Partnerships …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Peptide And Oligonucleotide CDMO Market Size Growth Forecast: What to Expect by 2025? In recent years, the peptide and oligonucleotide cdmo market has witnessed a swift escalation in its size. From $2.16 billion in 2024, it is projected to surge up to $2.42 billion in 2025 with a compound
Oral Solid Dosage Pharmaceutical Formulation: Critical Driver Shaping the Chronic Disease Prevalence Drive Growth In The Oral Solid Dosage Pharmaceutical Formulation Market Market in 2025
Oral Solid Dosage Pharmaceutical Formulation: Critical Driver Shaping the Chroni …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Oral Solid Dosage Pharmaceutical Formulation Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for oral solid dosage pharmaceutical formulations has seen robust growth in the last few years. Its size is expected to increase from $618.34 billion in 2024 to $653.26 billion in

All 5 Releases


More Releases for Devices

Spinal Fusion Devices Market Size to Reach Valuation of $7.43 Billion by 2022 | …
Increase in adoption of minimally invasive spine surgery (MISS) presents lucrative opportunities for key players in the spinal fusion devices market. MISS is preferred to conventional techniques, owing to its associated benefits such as minimal cut or incision, which in turn reduces the chances of damage caused to the adjacent muscles. Spinal fusion devices market was valued at $5,867 million in 2015, and is projected to reach $7,435 million by 2022,
Global Beauty Devices Market Industry Insights Forecast to 2024, Coverage Cellul …
The global beauty devices market was valued at USD 39.1 billion in 2018 and is anticipated to grow at a CAGR of 18.4% during the forecast period. The significant growth in the beauty devices industry is imputed to the rise in prevalence of skin disorders, increasing rate of hormonal imbalance cases, an increase in the geriatric population, and growing awareness for beauty devices. Request for Free Sample Copy of this Research
Canada Anesthesia and Respiratory Devices Market Segments Including Airway Manag …
ReportsnReports added a new report on The Canada Anesthesia and Respiratory Devices Market report that delivers the clean elaborated structure of the Report comprising each and every business-related information of the market at a global level. The in-depth study on the current state which focuses on the major drivers and restraints for the key players. Canada Anesthesia and Respiratory Devices Market Industry research report provides granular analysis of the market
Global Beauty Devices Market Insights 2018 By Products Hair Growth Devices,Acne …
Description This report studies the global market size of Beauty Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Beauty Devices in these regions. This research report categorizes the global Beauty Devices market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers,
Wearable Electronic Devices Market,Wearable Electronic Devices Industry, Global …
Latest industry research report on: Global Wearable Electronic Devices Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Wearable Electronic Devices market status and forecast, categorizes the global Wearable Electronic Devices market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in United States, Europe, China, Japan, South Korea and Taiwan and other
Ophthalmic Devices Market By Product Function [Ophthalmic Surgery Devices (Refra …
Ophthalmology is a branch of medical sciences that deals with the structure, function, and various eye diseases. The ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. These devices gain increased importance and adoption due to high prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision related issues. Request Sample At: https://www.bigmarketresearch.com/request-sample/1074435 Increase in prevalence rate of eye related diseases such as glaucoma, cataract,